EUCTR2011-003604-21-AT进行中（未招募）不适用
The role of immunosuppressives in immunosenescence and immunotolerance in renal transplantation - Immunosuppressives and immunosenescence
niversitätsklinik für Innere Medizin IV, Medizinische Universität Innsbruck0 个研究点开始时间: 2011年9月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patients after renal transplantation:
- •- transplantation more than 1 year ago
- •- current therapy is Tacrolimus, Cyclosporin A or Sirolimus/Everolimus
- •- signed informed consent form
- •healthy controls:
- •- signed informed consent form
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •patients after renal transplantation:
- •- acute or chronic rejection
- •- dysfunction of the transplant
- •healthy controls:
- •- immunosuppressive therapy
- •- chronic infection with HBV, HCV or HIV
- •- chemotherapy
- •- pregnant women
研究者
相似试验
已完成
不适用
Effects of immunosuppressive agents on innate immunity in renal transplant patientsurinary tract infectionpyelonefritis10004018NL-OMON42130Academisch Medisch Centrum105
Unknown
不适用
PRIMAGE (Probiotics, Immunity and Ageing)InfluenzaNCT01066377University of Reading120
已完成
不适用
Synbiotic Approach to Immunity and Metabolism in the Elderly StudyHealthyNCT03168503University of Roehampton40
招募中
不适用
Analyzing the impact of aging on the immune system in the context of covid-19 vaccinatioCOVID-19JPRN-jRCT1050210014Hamazaki Yoko200
已完成
2 期
Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the ElderlyAgingNCT02874924The University of Texas Health Science Center at San Antonio34